References
- Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281–297.
- Brunt, E.M., et al., 2011. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology (Baltimore, MD.), 53, 810–820.
- Chin, L.J., et al., 2008. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer research, 68, 8535–8540.
- Friedewald, W.T., Levy, R.I., and Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18, 499–502.
- Gao, Y., et al., 2009. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis, 30, 2064–2069.
- Gao, L., et al., 2014. Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma. Tumour biology: the journal of the international society for oncodevelopmental biology and medicine, 35, 3861–3865.
- Huang, J., et al., 2015. An insertion/deletion polymorphism at miRNA-122 binding site in the IL-1A is associated with a reduced risk of cervical squamous cell carcinoma. Genetic testing and molecular biomarkers, 19, 331–334.
- Jazdzewski, K., et al., 2008. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proceedings of the national academy of sciences of the United States of America, 105, 7269–7274.
- Li, Z.H., et al., 2013. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer. Tumour biology: the journal of the international society for oncodevelopmental biology and medicine, 34, 3159–3163.
- Marchesini, G., et al., 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844–1850.
- Marchesini, G., et al., 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (Baltimore, Md.), 37, 917–923.
- Pan, X.M., et al., 2014. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk. Tumour biology: the journal of the international society for oncodevelopmental biology and medicine, 35, 831–835.
- Rorat, M., et al., 2013. Liver steatosis in Polish children assessed by medicolegal autopsies. World journal of pediatrics: WJP, 9, 68–72.
- Schaffner, F. and Thaler, H., 1986. Nonalcoholic fatty liver disease. Progress in liver diseases, 8, 283–298.
- Vetel¨ainen, R., et al., 2007. Steatosis as a risk factor in liver surgery. Annals of surgery, 245, 20–30.
- Yang, Z.H., et al., 2011. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Molecular carcinogenesis, 50, 208–214.
- Zeng, X.F., Li, J., and Li, S.B., 2014. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumour biology: the journal of the international society for oncodevelopmental biology and medicine, 35, 265–268.